Impact of Pretreatment Total Cholesterol Level Is Associated With Metastasis of Prostate Cancer
Metabolic syndrome is reported to play a role in the genesis and development not only of angina, arteriosclerosis, diabetes, and osteoporosis but also of prostate cancer. Hypercholesterolemia is a strong risk factor in prostate cancer development. The current study was conducted to analyze whether p...
Main Authors: | Hisashi Hirano, Hisamitsu Ide, Yan Lu, Yasuyuki Inoue, Hiroshi Okada, Shigeo Horie |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-04-01
|
Series: | American Journal of Men's Health |
Online Access: | https://doi.org/10.1177/1557988320918788 |
Similar Items
-
Efficacy of Testosterone Treatment in Hemodialysis Patients as Assessed by Aging Males’ Symptoms Scores: A Pilot Study
by: Yasuyuki Inoue, et al.
Published: (2018-09-01) -
Serum level of follicle-stimulating hormone is associated with extraprostatic extension of prostate cancer
by: Hisamitsu Ide
Published: (2013-09-01) -
CXC Chemokine/Receptor Axis Profile and Metastasis in Prostate Cancer
by: Naoya Nagaya, et al.
Published: (2020-10-01) -
The healthcare economics of medication for prostate cancer
by: Shigeo Horie
Published: (2015-12-01) -
Sarcopenia is a poor prognostic factor of castration-resistant prostate cancer treated with docetaxel therapy
by: Ayako Ohtaka, et al.
Published: (2019-03-01)